TherapeuticsMD (TXMD) Earnings Date & Reports

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories... Show more

Industry: #Pharmaceuticals Generic

Get AI intraday signals

A.I. Advisor

published Earnings

TXMD is expected to report earnings to fall 180.00% to 3 cents per share on March 31

TherapeuticsMD TXMD Stock Earnings Reports

Q4'24

Est.

$0.04

Q3'24

Missed

by $0.09

Q2'24

Missed

by $0.12

Q1'24

Missed

by $0.10

Q4'23

Est.

$-0.13

The last earnings report on November 12 showed earnings per share of -5 cents, missing the estimate of 3 cents. With 17.26K shares outstanding, the current market capitalization sits at 24.32M.

View a ticker or compare two or three

Compare

TXMD